General Range
FORCOXIB-90
Price on request/100 · MOQ 100 boxes
FORCOXIB-90 Tablets by Fortune Labs contain Etoricoxib 90 mg, a selective COX-2 inhibitor used to manage pain and inflammation associated with certain musculoskeletal conditions. Etoricoxib works by reducing prostaglandin production, helping relieve joint pain, swelling, and stiffness. FORCOXIB-90 may be prescribed for rheumatoid arthritis, ankylosing spondylitis, and selected acute painful conditions when clinically appropriate. Available in convenient 10 × 10 tablet blister packaging, this product is part of Fortune Labs' orthopedic pharmaceutical portfolio. Fortune Labs offers Orthopedic PCD Pharma Franchise and distribution opportunities across India. Contact Fortune Labs for wholesale pricing, product availability, monopoly franchise opportunities, and business enquiries. Use only as prescribed, as Etoricoxib may increase cardiovascular and gastrointestinal risks.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Etoricoxib 90 mg
- Packaging Type
- Blister Pack with Outer Carton
- Packaging Size
- 10 × 10
- Dosage Form
- Tablet
- Treatment
- Rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout-related pain, joint pain, inflammation, and selected musculoskeletal pain con
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
